The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.
Open accessAbstract
The class II transactivator (CIITA) has been shown to be required for major histocompatibility complex (MHC) class II gene expression in B cells and its deficiency is responsible for a hereditary MHC class II deficiency. Here we show that CIITA is also involved in the inducible expression of class II genes upon interferon gamma (IFN-gamma) treatment. The expression of CIITA is also inducible with IFN-gamma before the induction of MHC class II mRNA. In addition, CIITA mRNA expression does not require new protein synthesis, although new protein synthesis is necessary for the transcription of class II. This suggests that synthesis of new CIITA protein may be essential to induce class II gene expression. We also showed that the JAK1 protein tyrosine kinase activity is required to induce the expression of CIITA upon IFN-gamma stimulation. This finding indicates that CIITA is part of the signaling cascade from the IFN-gamma receptor to the activation of class II genes. In addition, the expression of CIITA is sufficient to activate class II genes in the absence of IFN-gamma stimulation suggesting that CIITA is the major regulatory factor for the inducible expression of class II genes. Together, these data suggest that CIITA is the IFN-inducible cycloheximide sensitive factor previously shown to be required for the induction of MHC class II gene expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Properties of Monoclonal Antibodies to Mouse Ig Allotypes, H-2, and Ia Antigens
Oi, V. T., Jones, P. P., Goding, J. W., Herzenberg, L. A., & Herzenberg, L. A. (1979) · Lymphocyte Hybridomas · doi:10.1007/978-3-642-67448-8_18 · Cited by 973
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899 · cited 2×
“Although the components of the ISGF3 complex are phosphorylated by IFN-a/B, Stat91 is the only protein of this complex that can be phosphorylated by both IFNot/fl and -3/(9-11, 13, 15, 32).”
A protein tyrosine kinase in the interferon αβ signaling pathway
Velazquez, L., Fellous, M., Stark, G. R., & Pellegrini, S. (1992) · Cell · doi:10.1016/0092-8674(92)90105-l · Cited by 872
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
Activation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775
The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction
Müller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A. G., Barbieri, G., Witthuhn, B. A., Schindler, C., et al. (1993) · Nature · doi:10.1038/366129a0 · Cited by 760
Schindler, C., Fu, X. Y., Improta, T., Aebersold, R., & Darnell, J. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7836 · Cited by 647
Levy, D. E., Kessler, D. S., Pine, R., Reich, N., & Darnell, J. E. (1988) · Genes & Development · doi:10.1101/gad.2.4.383 · Cited by 559
Sequences And Factors: A Guide To Mhc Class-Ii Transcription
Glimcher, L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.13 · Cited by 534
Watling, D., Guschin, D., Müller, M., Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Rogers, N. C., Schindler, C., Stark, G. R., Ihle, J. N., et al. (1993) · Nature · doi:10.1038/366166a0 · Cited by 533
Cited by
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W. O., Wahl, A., Garcia, J. V., Reichenspurner, H., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0016-3 · Cited by 758
Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response
Sokol, C. L., Chu, N.-Q., Yu, S., Nish, S. A., Laufer, T. M., & Medzhitov, R. (2009) · Nature Immunology · doi:10.1038/ni.1738 · Cited by 619
The Bare Lymphocyte Syndrome and the Regulation of MHC Expression
Reith, W., & Mach, B. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.331 · Cited by 518
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer
Axelrod, M. L., Cook, R. S., Johnson, D. B., & Balko, J. M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3200 · Cited by 490
REGULATION OF MHC CLASS II GENES: Lessons from a Disease
Mach, B., Steimle, V., Martinez-Soria, E., & Reith, W. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.301 · Cited by 486
Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus
Borza, C. M., & Hutt-Fletcher, L. M. (2002) · Nature Medicine · doi:10.1038/nm0602-594 · Cited by 484
NLR family member NLRC5 is a transcriptional regulator of MHC class I genes
Meissner, T. B., Li, A., Biswas, A., Lee, K.-H., Liu, Y.-J., Bayir, E., Iliopoulos, D., van den Elsen, P. J., & Kobayashi, K. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008684107 · Cited by 447
“Discussion Since the complementation cloning of CIITA fromMHC class IIdeficient patients in 1993, CIITA has been often referred to as a master regulator of MHC class II expression, because CIITA is required for both constitutive and IFN-γ–inducible transcription of MHC class II genes (15, 20, 32).”
BackgroundInfluentialInterferon-γ: Biology and Role in Pathogenesis
Billiau, A. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60428-9 · Cited by 433
NLRC5: a key regulator of MHC class I-dependent immune responses
Kobayashi, K. S., & van den Elsen, P. J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3339 · Cited by 384
Muhlethaler-Mottet, A., Di Berardino, W., Otten, L. A., & Mach, B. (1998) · Immunity · doi:10.1016/s1074-7613(00)80468-9 · Cited by 377
Apps, R., Murphy, S. P., Fernando, R., Gardner, L., Ahad, T., & Moffett, A. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.03019.x · Cited by 360
Chang, C.-H., Guerder, S., Hong, S.-C., van Ewijk, W., & Flavell, R. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80681-0 · Cited by 350
Self-citationThe role of gamma interferon in antimicrobial immunity
Shtrichman, R., & Samuel, C. E. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00199-5 · Cited by 334
Tomazin, R., Boname, J., Hegde, N. R., Lewinsohn, D. M., Altschuler, Y., Jones, T. R., Cresswell, P., Nelson, J. A., Riddell, S. R., & Johnson, D. C. (1999) · Nature Medicine · doi:10.1038/12478 · Cited by 278
Class II transactivator regulates the expression of multiple genes involved in antigen presentation.
Chang, C. H., & Flavell, R. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.765 · Cited by 267
Self-citationKanazawa, S., Okamoto, T., & Peterlin, B. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)80159-4 · Cited by 262
Induction of MHC Class I Expression by the MHC Class II Transactivator CIITA
Martin, B. K., Chin, K.-C., Olsen, J. C., Skinner, C. A., Dey, A., Ozato, K., & Ting, J. P.-Y. (1997) · Immunity · doi:10.1016/s1074-7613(00)80347-7 · Cited by 208
Interferon Regulatory Factor 1 Is Required for Mouse Gbp Gene Activation by Gamma Interferon
Briken, V., Ruffner, H., Schultz, U., Schwarz, A., Reis, L. F. L., Strehlow, I., Decker, T., & Staeheli, P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.975 · Cited by 143
“The induced factor required for IFN-g-triggered activation of the major histocompatibility complex class II genes was recently identified as transcription factor CIITA (4).”
BackgroundResultInfluential
Metadata
- Authors
- Chang, C. H., Fontes, J. D., Peterlin, M., & Flavell, R. A.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-10-01
- Volume
- 180
- Issue
- 4
- Pages
- 1367-1374
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1996202980
- Cited by
- 329
- References
- 27
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.